GlycoNex (ROCO:4168) Cyclically Adjusted FCF per Share: NT$-2.58 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4168 GlycoNex Inc ROCO:4168
57 GF Score
Price NT$22.25
GF Value NT$76.27
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is GlycoNex Cyclically Adjusted FCF per Share?

GlycoNex ROCO:4168 +0.91% 57 Cyclically Adjusted FCF per Share is NT$-2.58 as of Dec. 2025. GuruFocus rates ROCO:4168 with a GF Score™ of 57/100 and a GF Value™ of NT$76.27 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

GlycoNex's adjusted free cash flow per share for the three months ended in Dec. 2025 was NT$-0.537. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-2.58 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of GlycoNex was 10.80% per year. The lowest was -3.20% per year. And the median was -2.80% per year.

As of today (2026-08-03), GlycoNex's current stock price is NT$22.25. GlycoNex's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2025 was NT$-2.58. GlycoNex's Cyclically Adjusted Price-to-FCF of today is .


GlycoNex  (ROCO:4168) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


GlycoNex Cyclically Adjusted FCF per Share Related Terms


GlycoNex Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for GlycoNex's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlycoNex Cyclically Adjusted FCF per Share Chart

GlycoNex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.38 -3.63 -3.68 -3.67 -2.58

GlycoNex Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.67 -3.31 -2.73 -2.83 -2.58

ROCO:4168 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, GlycoNex's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlycoNex Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlycoNex's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where GlycoNex's Cyclically Adjusted Price-to-FCF falls into.


ROCO:4168
57GF Score
GlycoNex Inc ROCO:4168
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GlycoNex Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GlycoNex's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.537/324.0540*324.0540
=-0.537

Current CPI (Dec. 2025) = 324.0540.

GlycoNex Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -1.139 238.132 -1.550
201606 -0.472 241.018 -0.635
201609 -0.871 241.428 -1.169
201612 -0.737 241.432 -0.989
201703 -0.662 243.801 -0.880
201706 -0.923 244.955 -1.221
201709 -0.521 246.819 -0.684
201712 -0.427 246.524 -0.561
201803 -0.802 249.554 -1.041
201806 -0.587 251.989 -0.755
201809 -0.421 252.439 -0.540
201812 -0.595 251.233 -0.767
201903 -0.550 254.202 -0.701
201906 -0.710 256.143 -0.898
201909 -0.733 256.759 -0.925
201912 -0.369 256.974 -0.465
202003 -0.682 258.115 -0.856
202006 -0.413 257.797 -0.519
202009 -0.287 260.280 -0.357
202012 -0.313 260.474 -0.389
202103 -0.416 264.877 -0.509
202106 -0.365 271.696 -0.435
202109 -0.486 274.310 -0.574
202112 -0.254 278.802 -0.295
202203 -0.345 287.504 -0.389
202206 -0.485 296.311 -0.530
202209 -0.525 296.808 -0.573
202212 -0.406 296.797 -0.443
202303 -0.569 301.836 -0.611
202306 -0.399 305.109 -0.424
202309 -0.649 307.789 -0.683
202312 -0.341 306.746 -0.360
202403 -0.550 312.332 -0.571
202406 -0.884 314.175 -0.912
202409 -0.352 315.301 -0.362
202412 -0.584 315.605 -0.600
202503 -0.419 319.799 -0.425
202506 -0.458 322.561 -0.460
202509 -0.168 324.800 -0.168
202512 -0.537 324.054 -0.537

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$-2.58 mean?
GlycoNex (ROCO:4168) has a Cyclically Adjusted FCF per Share of NT$-2.58 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on GlycoNex and its competitors.
Is GlycoNex's Cyclically Adjusted FCF per Share too high?
GlycoNex's current Cyclically Adjusted FCF per Share is NT$-2.58. Overall, GlycoNex has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GlycoNex's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
GlycoNex's Cyclically Adjusted FCF per Share of NT$-2.58 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on GlycoNex and its competitors. GlycoNex's current Cyclically Adjusted FCF per Share is NT$-2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlycoNex stock overvalued right now?
Based on GuruFocus' analysis, GlycoNex (ROCO:4168) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$76.27, compared to a current price of NT$22.25 — trading 70.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$-2.58. GlycoNex's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For GlycoNex (ROCO:4168), the current Cyclically Adjusted FCF per Share is NT$-2.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GlycoNex (ROCO:4168) Overvalued in 2026?

Based on GuruFocus' analysis, GlycoNex stock appears to be undervalued. The current stock price of NT$22.25 is trading 70.8% below its estimated GF Value™ of NT$76.27. GuruFocus considers GlycoNex to be Significantly Undervalued.

Key valuation signals for ROCO:4168:

  • Cyclically Adjusted FCF per Share: NT$-2.58
  • GF Value™: NT$76.27 vs. price of NT$22.25 (70.8% below fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GlycoNex Business Description

Address Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan-based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The other services provided by the firm include functional evaluation, antibody research, and antibody engineering. It has two reportable segments: antibody new drug, which derives maximum revenue, and exclusive investment. Geographically, the group derives maximum revenue from Taiwan and the rest from Japan.
57GF Score

Get the complete analysis for ROCO:4168

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.25
Price
NT$76.27
GF Value